Pharma Mar, S.A. Stock: price and insider trades · Spain

Every trade that managers of Pharma Mar, S.A. disclose to CNMV is tracked on this page. The company sits in the Healthcare & Pharma sector and is based in Colmenar Viejo, Spain. It was founded in 1986. The last twelve months, up to 18 October 2026, brought 13 filings signed by 9 insiders.

The record shows 8 purchases on the open market worth €86k, made by 5 insiders, against 1 sale worth €6,600 by 1 insider. On balance, insiders were net buyers of €79k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 3 board members and 2 chief executives. Fernando Martín-Delgado Santos filed the largest purchase, €37k, on 24 October 2025, which represents 0.0022% of the company's market value.

The data flag 5 purchases as part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (14 October 2026) now reads 4 days. Typically, a trade is published a median of 2 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades.

For context, the typical company on the same exchange (median of 102 companies) published 7 filings over the same period, against 13 filings here. Since 2021, the database holds 50 purchases and 1 sale by insiders of the company.

In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Every figure here comes from the filings published by CNMV and describes the past, not future prices; it is not investment advice.